Turnstone Biologics Corp (NASDAQ:TSBX)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 2.06. At the close of trading, the stock’s price was $0.45, to imply a decrease of -6.78% or -$0.03 in intraday trading. The TSBX share’s 52-week high remains $5.75, putting it -1177.78% down since that peak but still an impressive 11.11% since price per share fell to its 52-week low of $0.40. The company has a valuation of $10.31M, with an average of 0.46 million shares in intraday trading volume over the past 10 days and average of 204.03K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Turnstone Biologics Corp (TSBX), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give TSBX a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.
Turnstone Biologics Corp (NASDAQ:TSBX) trade information
After registering a -6.78% downside in the last session, Turnstone Biologics Corp (TSBX) has traded red over the past five days. The 5-day price performance for the stock is 3.00%, and -20.66% over 30 days. With these gigs, the year-to-date price performance is -10.28%. Short interest in Turnstone Biologics Corp (NASDAQ:TSBX) saw shorts transact 0.47 million shares and set a 3.24 days time to cover.
The extremes give us $0.5 and $0.5 for target low and target high price respectively. As such, TSBX has been trading -11.11% off suggested target high and -11.11% from its likely low.
Turnstone Biologics Corp (TSBX) estimates and forecasts
The rating firms project that company’s revenue will shrink -100.00% compared to the previous financial year.
TSBX Dividends
Turnstone Biologics Corp has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
We also have Vanguard Total Stock Market Index Fund and Fidelity Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Turnstone Biologics Corp (TSBX) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 495.07 shares. This is just over 2.14% of the total shares, with a market valuation of $0.22 million. Data from the same date shows that the other fund manager holds a little less at 85.73, or 0.37% of the shares, all valued at about 38218.0.
